BioSpace News Archive

The ‘CPhI Verified’ certificate will provide pharma companies with an internationally accredited pre-qualification service.

Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported recent business highlights and second quarter 2021 financial results.

Quotient Limited, a commercial-stage diagnostics company, announced that Jeremy Stackawitz has notified the Company that he is resigning from his position as Chief Commercial Officer.

Mahana Therapeutics has completed a $61 million Series B financing.

Be Biopharma today announced that Krishnan Viswanadhan, Pharm.D., MBA, has been appointed President and Chief Operating Officer and Brad Hartman has joined as Chief People Officer.

Skye Bioscience, Inc. announced today that Karam Takhar, VP of Corporate Development and Investor Relations, Skye Bioscience is scheduled to present virtually in the H.C. Wainwright Ophthalmology Conference on Tuesday, August 17 at 7:00 AM ET.

Alverno Laboratories, a provider of high-quality diagnostic testing services and one of the largest integrated laboratory networks in the United States, and Ibex Medical Analytics, the market leader in artificial intelligence (AI)-powered cancer diagnostics, today announced a deal to deploy Ibex’s AI-powered Galen™ platform, helping pathologists provide accurate diagnosis and improved care for cancer patients.

Lucia Health Guidelines, a company applying machine learning at the point of care in the treatment of atrial fibrillation (AFib), today announced the publication of its AIM-HIGHER proof-of-concept study in the Journal of the American College of Emergency Physicians (JACEP) Open.

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today highlights recent findings from North Carolina State University, that its new treatment for mast cell cancers, known as HT-KIT, reduces the number of mast cells by “mutating” the messenger RNA (mRNA) before it can deliver instructions for manufacturing the gene responsible for cell proliferation.

H Clinical has completed consolidation of decentralized clinical trial (DCT) and in-home visit operations in Latin America.